This inventor holds 40 USPTO granted patents, primarily in Biotechnology Innovations. Top assignees: Smithkline Beecham Corporation, Affinium Pharmaceuticals, Inc., Other. Active years: 1999-2008.
Location History:
- Surrey, GB (2000)
- Cotmandene, GB (1999 - 2001)
- Dorkings Surrey, GB (2001)
- Dorking England, GB (2001)
- Dorking Surrey, GB (1999 - 2002)
- Dorking, GB (1999 - 2007)
- Durking Surrey, GB (2008)
Company Filing History:
27 out of 2,198Â 
2 out of 33Â 
17 out of 834,307Â Years Active: 1999-2008
Areas of Expertise:
Title: Judith M. Ward: Innovator in Biotech
Introduction
Judith M. Ward, based in Dorking, GB, is a prominent inventor known for her significant contributions to biotechnology. With an impressive portfolio of 40 patents, she has made noteworthy advancements in the field, particularly in the area of Staphylococcal polynucleotides and their applications.
Latest Patents
One of her latest innovations revolves around newly identified Staphylococcal polynucleotides and the polypeptides encoded by these sequences. This invention highlights not only the methods for producing these polynucleotides and polypeptides but also the recombinant host cells transformed with them. Furthermore, her work offers intriguing methodologies for inhibiting the biosynthesis or action of such polynucleotides and polypeptides, emphasizing their therapeutic uses.
Career Highlights
Throughout her career, Judith has collaborated with notable organizations, including SmithKline Beecham Corporation. Her work in the corporation and other research environments has cemented her reputation as a leader in her field.
Collaborations
Judith has had the privilege of working alongside esteemed colleagues such as Martin M. Rosenberg and John Edward Hodgson. These collaborations have further enriched her research initiatives and patent developments, showcasing her ability to work within multidisciplinary teams.
Conclusion
In conclusion, Judith M. Ward's innovative spirit and dedication to advancing biotechnology are evidenced by her significant number of patents and her impactful collaborations. Her ongoing contributions promise to shape future therapies and applications within the industry.